BridgeBio Pharma (BBIO) PT Raised to $91 at Goldman Sachs, Following Clinical Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: BBIO) | Delayed: 69.37 +1.22 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.15 | 52 Week High | $ | |||
| Open | $68.14 | 52 Week Low | $ | |||
| Day High | $69.64 | P/E | N/A | |||
| Day Low | $67.99 | EPS | $ | |||
| Volume | 2,041,951 | |||||
